UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

The journal of clinical endocrinology and metabolism, 2009-10, Vol.94 (10), p.3842-3848

2009

Volltextzugriff (PDF)

Endocrine consequences of breast cancer therapy and survivorship

Climacteric : the journal of the International Menopause Society, 2024-08, Vol.27 (4), p.333-339

2024

Volltextzugriff (PDF)

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Human reproduction (Oxford), 2008-10, Vol.23 (10), p.2352-2358

2008

Volltextzugriff (PDF)

Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Diabetologia, 2014-11, Vol.57 (11), p.2296-2303

2014

Volltextzugriff (PDF)

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Medical journal of Australia, 2022-04, Vol.216 (6), p.283-284

2022

Volltextzugriff (PDF)

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2022-11, Vol.400 (10364), p.1704-1711

2022

Volltextzugriff (PDF)

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

The journal of clinical endocrinology and metabolism, 2021-04, Vol.106 (4), p.e1917-e1918

2021

Volltextzugriff (PDF)

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Medical journal of Australia, 2011-09, Vol.195 (6), p.S65-S112

2011

Volltextzugriff (PDF)

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

The journal of clinical endocrinology and metabolism, 2023-12, Vol.108 (12), p.e1560-e1570

2023

Volltextzugriff (PDF)

The Importance of Measuring Ionized Calcium in Characterizing Calcium Status and Diagnosing Primary Hyperparathyroidism

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3138-3145

2012

Volltextzugriff (PDF)

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Medical journal of Australia, 2016-08, Vol.205 (4), p.173-178

2016

Volltextzugriff (PDF)

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

European journal of human genetics : EJHG, 2016-02, Vol.24 (2), p.284-290

2016

Volltextzugriff (PDF)

Letter to the Editor: “Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia”

The journal of clinical endocrinology and metabolism, 2019-02, Vol.104 (2), p.461-462

2019

Volltextzugriff (PDF)

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Menopause (New York, N.Y.), 2023-04, Vol.30 (4), p.427-436

2023

Volltextzugriff (PDF)

Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

The journal of clinical endocrinology and metabolism, 2021-08, Vol.106 (8), p.e3143-e3158

2021

Volltextzugriff (PDF)

Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

The journal of clinical endocrinology and metabolism, 2023-12, Vol.109 (1), p.e25-e31

2023

Volltextzugriff (PDF)

Induction of lactation in a patient with complete androgen insensitivity syndrome

Endocrinology, diabetes & metabolism case reports, 2023-10, Vol.2023 (4), p.1-4

2023

Volltextzugriff (PDF)

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Medical journal of Australia, 2022-09, Vol.217 (5), p.268-268

2022

Volltextzugriff (PDF)

Establishing a Total Hip T-Score Threshold to Measure Contralateral Hip Bone Mineral Density: Avoiding Missed Diagnosis of Osteoporosis

Journal of clinical densitometry, 2022-10, Vol.25 (4), p.577-586

2022

Volltextzugriff (PDF)

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

European journal of endocrinology, 2023-07, Vol.189 (1), p.50-57

2023

Volltextzugriff (PDF)

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

European journal of endocrinology, 2022-01, Vol.186 (3), p.307-318

2022

Volltextzugriff (PDF)

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

PloS one, 2013-08, Vol.8 (8), p.e70700-e70700

2013

Volltextzugriff (PDF)

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Metabolism, clinical and experimental, 2014-08, Vol.63 (8), p.1071-1077

2014

Volltextzugriff (PDF)

Female Sexual Function and Dysfunction in the Reproductive Years: The Influence of Endogenous and Exogenous Sex Hormones

Journal of sexual medicine, 2008-10, Vol.5 (10), p.2282-2290

Stuckey, Bronwyn G.A.

2008

Volltextzugriff (PDF)

Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial

Diabetologia, 2018-09, Vol.61 (9), p.1918-1922

2018

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(142)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy

Endocrine consequences of breast cancer therapy and survivorship

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

Letter to the Editor: “Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline”

Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

The Importance of Measuring Ionized Calcium in Characterizing Calcium Status and Diagnosing Primary Hyperparathyroidism

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes

Letter to the Editor: “Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia”

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT

Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

Induction of lactation in a patient with complete androgen insensitivity syndrome

Vertebral fractures after denosumab discontinuation for dental procedures: a consequence of distorted perceptions of risk

Establishing a Total Hip T-Score Threshold to Measure Contralateral Hip Bone Mineral Density: Avoiding Missed Diagnosis of Osteoporosis

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

Loss of the nuclear receptor corepressor SLIRP compromises male fertility

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis

Female Sexual Function and Dysfunction in the Reproductive Years: The Influence of Endogenous and Exogenous Sex Hormones

Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial

Suchergebnisse filtern